Advanced NanoTherapies Revenue and Competitors
Estimated Revenue & Valuation
- Advanced NanoTherapies's estimated annual revenue is currently $2.5M per year.
- Advanced NanoTherapies's estimated revenue per employee is $125,500
- Advanced NanoTherapies's total funding is $5.3M.
Employee Data
- Advanced NanoTherapies has 20 Employees.
- Advanced NanoTherapies grew their employee count by 0% last year.
Advanced NanoTherapies's People
Name | Title | Email/Phone |
---|---|---|
1 | President, CEO, and co-founder | Reveal Email/Phone |
2 | President, CEO and Co-Founder | Reveal Email/Phone |
3 | Director - Engineering | Reveal Email/Phone |
4 | Sr. Director R&D | Reveal Email/Phone |
5 | Quality Manager | Reveal Email/Phone |
6 | Senior Manager, Product Development | Reveal Email/Phone |
7 | Medical Writer | Reveal Email/Phone |
8 | Product Development Engineer | Reveal Email/Phone |
9 | Research Scientist | Reveal Email/Phone |
Advanced NanoTherapies Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $24.1M | 96 | 19% | N/A | N/A |
#2 | $9.5M | 38 | 12% | N/A | N/A |
#3 | $4M | 16 | -11% | N/A | N/A |
#4 | $7.8M | 31 | -3% | N/A | N/A |
#5 | $5M | 20 | -5% | N/A | N/A |
#6 | $49.9M | 199 | -8% | N/A | N/A |
#7 | $16.8M | 67 | -17% | $63.2M | N/A |
#8 | $9.3M | 37 | -7% | N/A | N/A |
#9 | $36.6M | 146 | 22% | N/A | N/A |
#10 | $64.3M | 205 | 3% | $502M | N/A |
What Is Advanced NanoTherapies?
AdvNanoT is based on biodegradable nanoparticles (NP) specifically designed to have higher vascular uptake and cellular retention. We are developing novel Sirolimus-based medical devices to treat atherosclerosis and blockage for Coronary Artery Disease (CAD) and Peripheral Artery Disease (PAD).
keywords:N/A$5.3M
Total Funding
20
Number of Employees
$2.5M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.8M | 20 | -20% | N/A |
#2 | $5.6M | 21 | 50% | $18M |
#3 | $2.1M | 21 | -34% | N/A |
#4 | $2.3M | 23 | N/A | N/A |
#5 | $4.3M | 23 | -78% | N/A |